Emergence of Th2-like cells after anti-CD3 monoclonal antibody administration in mice.
Wissing
M
M
Hôpital Erasme, Université Libre de Bruxelles, Belgium.
Alegre
M L
ML
Abramowicz
D
D
Willems
F
F
Donckier
V
V
Vanderhaeghen
M L
ML
Leo
O
O
Goldman
M
M
D000818:Animals; D000911:Antibodies, Monoclonal / Q000494:pharmacology*; D017252:CD3 Complex / Q000276:immunology*; D016207:Cytokines / Q000096:biosynthesis* / Q000097:blood; D004334:Drug Administration Schedule; D007165:Immunosuppression Therapy; D007371:Interferon-gamma / Q000096:biosynthesis / Q000097:blood; D016753:Interleukin-10 / Q000096:biosynthesis / Q000097:blood; D007376:Interleukin-2 / Q000096:biosynthesis / Q000097:blood; D015847:Interleukin-4 / Q000096:biosynthesis / Q000097:blood; D051379:Mice; D008807:Mice, Inbred BALB C; D013601:T-Lymphocytes / Q000276:immunology*; D013997:Time Factors
D000911:Antibodies, Monoclonal; D017252:CD3 Complex; D016207:Cytokines; D007376:Interleukin-2; D016753:Interleukin-10; D015847:Interleukin-4; D007371:Interferon-gamma